BCM
CASI

Bridgeway Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

Bridgeway Capital Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,340
Closed -$40K – 1271
2021
Q3 		$40K Buy
+3,340
New +$45.2K ﹤0.01% 1275
2021
Q2 		– Sell
-63,000
Closed -$1.51M – 1343
2021
Q1 		$1.51M Buy
63,000
+42,480
+207% +$1.19M 0.03% 715
2020
Q4 		$605K Hold
20,520
– – 0.01% 881
2020
Q3 		$314K Hold
20,520
– – 0.01% 1045
2020
Q2 		$513K Buy
20,520
+6,110
+42% +$133K 0.01% 849
2020
Q1 		$294K Buy
+14,410
New +$344K 0.01% 934

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return